Skip to content

Clinical trials

Phase 2 Neutropenia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neutropenia Phase: Phase 2 Country / region: United States Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20021
20032
20041
20051
20062
20071
20081
20092
20111
20122
20132
20141
20151
20171
20221
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Recruiting3
Terminated2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)6
Alliance for Clinical Trials in Oncology2
M.D. Anderson Cancer Center2
Memorial Sloan Kettering Cancer Center2
National Cancer Institute (NCI)2
Amgen1
AviGenics1
Cellerant Therapeutics1
EVIVE Biotechnology1
OHSU Knight Cancer Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neutropenia30
Leukemia9
Thrombocytopenia9
Anemia6
Leukemia, Myeloid, Acute5
Myelodysplastic Syndromes5
Anemia, Aplastic4
Autoimmune Diseases4
Blast Crisis3
Lung Neoplasms3

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.